MANAGEMENT OF TYPE 2 HEPARIN-INDUCED THROMBOCYTOPENIA PRIOR TO HEARTMATE 3 LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION: A CASE SERIES

Authors :: Himabindu Vidula
Igor Gosev
Jennifer Falvey
Jacqueline H Morris
Bryan Barrus
Syed Yaseen Naqvi
Source :: Journal of the American College of Cardiology. 73:2217
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.
Abstract: Heparin-induced thrombocytopenia (HIT) is a rare side effect of heparin therapy that can result in life threatening thrombosis. It presents a therapeutic challenge in patients undergoing HeartMate 3 (HM3) left ventricular assist device (LVAD) implantation. Patient 1: A 69 year old male with

Subjects :: medicine.medical_specialty
Side effect
business.industry
medicine.medical_treatment
medicine.disease
Thrombosis
Ventricular assist device
Internal medicine
Heparin-induced thrombocytopenia
Cardiology
medicine
In patient
Cardiology and Cardiovascular Medicine
Heparin therapy
business

Tools